| Line Item | 2024-08-30 | Y/Y |
|---|---|---|
| Revenue | $1.17B | -18.8% |
| Cost of Revenue | $830.0M | -19.1% |
| Gross Profit | $340.8M | -17.9% |
| R&D Expense | $81.5M | -10.0% |
| SG&A Expense | $233.9M | -10.3% |
| Operating Income | $18.3M | +109.2% |
| Pre-tax Income | -$31.2M | +21.1% |
| Income Tax | $10.6M | +121.6% |
| Net Income | -$52.5M |
| Line Item | 2024-08-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $383.1M | +4.8% |
| Short-term Investments | $6.3M | -74.9% |
| Accounts Receivable | $251.7M | +14.8% |
| Inventory | $151.2M | -13.6% |
| Current Assets | $867.7M | -4.4% |
| Total Assets | $1.47B | -2.1% |
| Current Liabilities | $327.6M | -23.1% |
| Line Item | 2024-08-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $77.2M | -26.1% |
| Capital Expenditures | $19.4M | -50.7% |
| Investing Cash Flow | $107.6M | +136.0% |
| Financing Cash Flow | -$210.1M | -188.9% |
| Free Cash Flow | $57.8M | -11.1% |
| +72.0% |
| EPS (Basic) | -$1.00 | +73.5% |
| EPS (Diluted) | -$1.00 | +72.6% |
| Long-term Debt |
| $657.3M |
| -16.8% |
| Total Liabilities | $1.08B | -15.8% |
| Stockholders' Equity | $391.4M | +75.9% |